Molecule intelOpportunity: StrongEssential

Octreotide

16 brands · 9 companies · product forms

ATC: H01CB02

Opportunity snapshot

Launch attractiveness
50
Market saturation
24
Price room
100
Regulatory risk
0
16
brands
9
companies
Rs 15,586.59
median price
15
price points
69.62x
price spread
100
confidence %

Who competes here

Top companies by brand count · leader share 31%

Price room

Across observed sources and strengths
CheapestRs 3,415.17
MedianRs 15,586.59
Most expensiveRs 237,754.57
Spread69.62×
Sources: DRAP-official, DVAGO, Servaid

max/min price ratio 69.62x across 15 trusted points (Rs 3415.17-237754.57). NOTE: mixes strengths (graph prices carry no strength), so treat as indicative.

Brands & products on the market

Sample of 7 live products for Octreotide — each links to its own medicine page.

Why this score

Launch attractiveness

40% supply-gap(25) + 25% price-variation(100) + 20% low-competition(76) + 15% supply-disruption(0), damped by confidence(100). Higher = more attractive, less crowded opportunity.

Market saturation

9 canonical companies and 16 brands compete (saturation pegged at 30 companies / 150 brands).

Price room

max/min price ratio 69.62x across 15 trusted points (Rs 3415.17-237754.57). NOTE: mixes strengths (graph prices carry no strength), so treat as indicative.

Regulatory risk

No DRAP alerts on this molecule's brands.

Confidence

Full coverage.

Packaged brief for this strong opportunity?

Molecule page + company profiles + price-room analysis are the pilot package for pharma teams.

See packaged reports All 3868 molecules

Molecule intelligence as of 2026-07-30. Brand/company counts from DRAP registry and observed retail sources.

For medicine intelligence and professional reference only. Not medical advice.